Chemical Compound Review:
CHEMBL99869 4-[(E)-2-[[[2,4-dichloro-3- [[2-methyl-4...
Synonyms:
SureCN5936739, CHEBI:258876, AC1NSK0Q, FR190997, L024093
Aramori,
Zenkoh,
Morikawa,
Asano,
Hatori,
Sawai,
Kayakiri,
Satoh,
Inoue,
Abe,
Sawada,
Mizutani,
Inamura,
Iwami,
Nakahara,
Kojo,
Oku,
Notsu,
Dendorfer,
Wolfrum,
Schäfer,
Stewart,
Inamura,
Dominiak,
Ueno,
Naraba,
Kojima,
Morita,
Oh-ishi,
Hayashi,
Ishihara,
Kumagai,
Majima,
Aramori,
Zenkoh,
Morikawa,
Asano,
Hatori,
Sawai,
Kayakiri,
Satoh,
Inoue,
Abe,
Sawada,
Mizutani,
Inamura,
Nakahara,
Kojo,
Oku,
Notsu,
Paegelow,
Trzeczak,
Böckmann,
Vietinghoff,
Meini,
Bellucci,
Cucchi,
Giuliani,
Quartara,
Giolitti,
Zappitelli,
Rotondaro,
Boels,
Maggi,
- A nonpeptide mimic of bradykinin blunts the development of hypertension in young spontaneously hypertensive rats. Majima, M., Hayashi, I., Inamura, N., Fujita, T., Ogino, M. Hypertension (2000)
- FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response. Ueno, A., Naraba, H., Kojima, F., Morita, E., Oh-ishi, S. Immunopharmacology (1999)
- Potentiation of the vascular response to kinins by inhibition of myocardial kininases. Dendorfer, A., Wolfrum, S., Schäfer, U., Stewart, J.M., Inamura, N., Dominiak, P. Hypertension (2000)
- Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor. Aramori, I., Zenkoh, J., Morikawa, N., Asano, M., Hatori, C., Sawai, H., Kayakiri, H., Satoh, S., Inoue, T., Abe, Y., Sawada, Y., Mizutani, T., Inamura, N., Nakahara, K., Kojo, H., Oku, T., Notsu, Y. Mol. Pharmacol. (1997)
- Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997. Asano, M., Hatori, C., Sawai, H., Johki, S., Inamura, N., Kayakiri, H., Satoh, S., Abe, Y., Inoue, T., Sawada, Y., Mizutani, T., Oku, T., Nakahara, K. Br. J. Pharmacol. (1998)
- A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis. Bellucci, F., Meini, S., Cucchi, P., Catalani, C., Reichert, W., Zappitelli, S., Rotondaro, L., Quartara, L., Giolitti, A., Maggi, C.A. Br. J. Pharmacol. (2003)
- Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo. Hayashi, I., Ishihara, K., Kumagai, Y., Majima, M. Br. J. Pharmacol. (2001)
- Nonpeptide mimic of bradykinin with long-acting properties. Aramori, I., Zenkoh, J., Morikawa, N., Asano, M., Hatori, C., Sawai, H., Kayakiri, H., Satoh, S., Inoue, T., Abe, Y., Sawada, Y., Mizutani, T., Inamura, N., Iwami, M., Nakahara, K., Kojo, H., Oku, T., Notsu, Y. Immunopharmacology (1999)
- Anion secretory effects of a non-peptide mimic of bradykinin (FR190997) on mouse colon epithelium. Cuthbert, A.W. Immunopharmacology (1999)
- Migratory responses of polymorphonuclear leukocytes to kinin peptides. Paegelow, I., Trzeczak, S., Böckmann, S., Vietinghoff, G. Pharmacology (2002)
- Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology. Meini, S., Bellucci, F., Cucchi, P., Giuliani, S., Quartara, L., Giolitti, A., Zappitelli, S., Rotondaro, L., Boels, K., Maggi, C.A. Br. J. Pharmacol. (2004)
- Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Ito, H., Hayashi, I., Izumi, T., Majima, M. Br. J. Pharmacol. (2003)